医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

3M Prevails Against Seil Global Co. Ltd. in an Unfair Competition Action Related to 3M’s Dental Mixing Tip Products

2015年11月06日 AM03:56
このエントリーをはてなブックマークに追加


 

ST. PAUL, Minn. & NEUSS, Germany

3M announced today that a German district court ruled in favor of 3M in an unfair competition claim 3M filed against South Korea-based Seil Global Co. Ltd.

The court found Seil’s red-colored dental mixing tips looked confusingly similar to 3M´s dental mixing tips that are recognizable by their unique red color and marketed under the brand 3M™ ESPE™ Penta™ Mixing Tips. The decision is final, which means that Seil is permanently enjoined from selling its red mixing tips in Germany.

3M´s dental mixing tips are well-known in the market and have acquired competitive distinctiveness in Germany. The unique design of the Penta mixing tip that is also covered by a utility patent and a design registration provides users of the 3M™ ESPE™ Pentamix™ Mixing Units with a high quality tip that delivers the most uniform, consistent result. It also facilitates easier extrusion of the impression material.

3M is committed to improving oral care through continuous research and development investments. By protecting its intellectual property and ensuring genuine 3M products are distributed through secure, authorized channels, 3M helps dentists and their patients avoid the use of unauthentic products.

About 3M

At 3M, we apply science in collaborative ways to improve lives daily. With $32 billion in sales, our 90,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNewsroom.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151105006534/en/

CONTACT

3M
Lori Anderson, 651-733-0831

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Scientist.comがインク誌から「米国内で最も急成長中の非公開企業」のトップ10に指名される
  • Urban Drinking Water Challenge 2018 Announces Winners from USA, India and Bangladesh
  • CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in Esophageal Squamous Cell Cancer (ESCC) In China
  • AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China
  • STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement